Induction of a fibrogenic response in mouse colon by overexpression of monocyte chemoattractant protein 1

Gut

Volumn 55, Issue 5, 2006, Pages 662-670

  Motomura, Y ^a   Khan, W I ^a   El Sharkawy, R T ^a   Verma Gandhu, M ^a   Verdu, E F ^a   Gauldie, J ^b   Collins, S M ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; CD3 ANTIGEN; COLLAGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CHEMICAL ANALYSIS; COLON; CONTROLLED STUDY; FIBROGENESIS; GENE TRANSFER; HISTOPATHOLOGY; INTESTINE; MACROPHAGE; MALE; MOUSE; MYENTERIC PLEXUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALS; CHEMOKINE CCL2; COLLAGEN TYPE I; COLLAGEN TYPE III; COLON; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROSIS; GENETIC VECTORS; HISTOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES; MALE; MATRIX METALLOPROTEINASE 3; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECTUM; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSDUCTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 33646270895     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.068429     Document Type: Article

References (43)

1. Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002;8:244-50.
2. Freeman HJ. Natural history and clinical behavior of Crohn's disease extending beyond two decades. J Clin Gastroenterol 2003;37:216-19.
3. Longo WE, Virgo KS, Bahadursingh AN, et al. Patterns of disease and surgical treatment among United States veterans more than 50 years of age with ulcerative colitis. Am J Surg 2003;186:514-8.
4. Prudhomme M, Dozois RR, Godlewski G, et al. Anal canal strictures after ileal pouch-anal anastomosis. Dis Colon Rectum 2003;46:20-3.
5. Van Assche G, Geboes K, Rutgeerts P. Medical therapy for Crohn's disease strictures. Inflamm Bowel Dis 2004;10:55-60.
6. Sartor RB, Cromartie WJ, Powell DW, et al. Granulomatous enterocolitis induced in rats by purified bacterial cell wall fragments. Gastroenterology 1985;89:587-95.
7. Van Tol EA, Holt L, Li FL, et al. Bacterial cell wall polymers promote intestinal fibrosis by direct stimulation of myofibroblasts. Am J Physiol 1999;277:G245-55.
8. Morris GP, Beck PL, Herridge MS, et al. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989;96:795-803.
9. Lawrance IC, Wu F, Leite AZ, et al. A murine model of chronic inflammation-induced intestinal fibrosis down-regulated by antisense NF-kappa B. Gastroenterology 2003;125:1750-61.
10. Rivera-Nieves J, Bamias G, Vidrich A, et al. Emergence of perianal fistulizing disease in the SAMP1/YitFc mouse, a spontaneous model of chronic ileitis. Gastroenterology 2003;124:972-82.
11. Zhang K, Gharaee-Kermani M, Jones ML, et al. Lung monocyte chemoattractant protein-1 gene expression in bleomycin-induced pulmonary fibrosis. J Immunol 1994;153:4733-41.
12. Inoshima I, Kuwano K, Hamada N, et al. Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 2004;286:L1038-44.
13. Lloyd CM, Minto AW, Dorf ME, et al. RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J Exp Med 1997;185:1371-80.
14. Kitagawa K, Wada T, Furuichi K, et al. Blockade of CCR2 ameliorates progressive fibrosis in kidney. Am J Pathol 2004;165:237-46.
15. Marra F, DeFranco R, Grappone C, et al. Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. Am J Pathol 1998;152:423-30.
16. Inoue M, Ino Y, Gibo J, et al. The role of monocyte chemoattractant protein-1 in experimental chronic pancreatitis model induced by dibutyltin dichloride in rats. Pancreas 2002;25:e64-70.
17. Leonard EJ, Yoshimura T. Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today 1990;11:97-101.
18. Mukaida N, Harada A, Matsushima K. Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions. Cytokine Growth Factor Rev 1998;9:9-23.
19. Grimm MC, Elsbury SK, Pavli P, et al. Enhanced expression and production of monocyte chemoattractant protein-1 in inflammatory bowel disease mucosa. J Leukoc Biol 1996;59:804-12.
20. Mazzucchelli L, Hauser C, Zgraggen K, et al. Differential in situ expression of the genes encoding the chemokines MCP-1 and RANTES in human inflammatory bowel disease. J Pathol 1996;178:201-6.
21. Bett AJ, Haddara W, Prevac L, et al. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 2. Proc Natl Acad Sci U S A 1994;91:8802-6.
22. Xing Z, Ohkawara Y, Jordana M, et al. Transfer of granulocyte-macrophage colony-stimulating factor gene to rat lung induces eosinophilia, monocytosis, and fibrotic reactions. J Clin Invest 1996;97:1102-10.
23. Motomura Y, Kanbayashi H, Khan WI, et al. The gene transfer of soluble VEGF type i receptor (Flt-1) attenuates peritoneal fibrosis formation in mice but not soluble TGF-β type II receptor gene transfer. Am J Physiol Gastrointest Liver Physiol 2005;288:G143-50.
24. Antoniades HN, Neville-Golden J, Galanopoulos T, et al. Expression of monocyte chemoattractant protein 1 mRNA in human idiopathic pulmonary fibrosis. Proc Natl Acad Sci U S A 1992;89:5371-5.
25. Egashira K, Koyanagi M, Kitamoto S, et al. Anti-monocyte chemoattractant protein-1 gene therapy inhibits vascular remodeling in rats: blockade of MCP-1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesis. FASEB J 2000;14:1974-8.
26. Tsuruta S, Nakamuta M, Enjoji M, et al. Anti-monocyte chemoattractant protein-1 gene therapy prevents dimethylnitrosamine-induced hepatic fibrosis in rats. Int J Mol Med 2004;14:837-42.
27. Wada T, Furuichi K, Sakai N, et al. Gene therapy via blockade of monocyte chemoattractant protein-1 for renal fibrosis. J Am Soc Nephrol 2004;15:940-8.
28. high T cells. Eur J Immunol 2001;31:1465-74.
29. Sun FF, Lai P-S, Vue G, et al. Pattern of cytokine and adhesion molecule mRNA in hapten-induced relapsing colon inflammation in the rat. Inflammation 2001;25:33-45.
30. Banks C, Bateman A, Payne R, et al. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. J Pathol 2003;199:28-35.
31. McCormack G, Moriarty D, O'Donoghue DP, et al. Tissue cytokine and chemokine expression in inflammatory bowel disease. Inflamm Res 2001;50:491-5.
32. Rallis TS, Frydas S, Soubasis N, et al. Monocyte chemotactic protein-1 in a randomized placebo-controlled study of canine plasmacytic-lymphocytic colitis. Int J Immunopathol Pharmacol 2002;15:107-12.
33. Vallance BA, Gunawan I, Hewlett BR, et al. Adenoviral gene transfer of active TGF-β to the colonic epithelium causes fibrosis and strictures. Gastroenterology 1999;116:A685.
34. Pucilowska JB, McNaughton KK, Mohapatra NK, et al. IGF-1 and procollagen a1(I) are coexpressed in a subset of mesenchymal cells in active Crohn's disease. Am J Physiol Gastrointest Liver Physiol 2000;279:G1307-22.
35. Graham MF, Diegelmann RF, Elson CO, et al. Collagen content and types in the intestinal strictures of Crohn's disease. Gastroenterology 1988;94:257-65.
36. Stallmach A, Schuppan D, Riese HH, et al. Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Crohn's disease. Gastroenterology 1992;102:1920-9.
37. Lawrance IC, Maxwell L, Doe W. Inflammation location, but not type, determines the increase in TGF-beta1 and IGF-1 expression and collagen deposition in IBD intestine. Inflamm Bowel Dis 2001;7:16-26.
38. Gunn MD, Nelken NA, Liao X, et al. Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation. J Immunol 1997;158:376-83.
39. Sempowski GD, Chess PR, Phipps RP. CD40 is a functional activation antigen and B7-independent T cell costimulatory molecule on normal human lung fibroblasts. J Immunol 1997;158:4670-7.
40. Kaufman J, Sime PJ, Phipps RP. Expression of CD154 (CD40 ligand) by human lung fibroblasts: differential regulation by IFN-gamma and IL-13, and implications for fibrosis. J Immunol 2004;172:1862-71.
41. Gharaee-Kermani M, Denholm EM, Phan SH. Costimulation of fibroblast collagen and transforming growth factor beta1 gene expression by monocyte chemoattractant protein-1 via specific receptors. J Biol Chem 1996;271:17779-84.
42. Eickelberg O, Kohler E, Reichenberger F, et al. Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-beta1 and TGF-beta3. Am J Physiol 1999;276:L814-24.
43. Yamomoto T, Eckes B, Mauch C, et al. Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1 alpha loop. J Immunol 2000;164:6174-9.